Literature DB >> 11581011

Effect of cytokines and growth factors on the secretion of inhibin A, activin A and follistatin by term placental villous trophoblasts in culture.

A Mohan1, J Asselin, I L Sargent, N P Groome, S Muttukrishna.   

Abstract

OBJECTIVE: Maternal serum inhibin A and activin A are higher in pre-eclampsia than in normal pregnancy. The placenta is a source of these proteins in pregnancy. The aim of this study was to investigate the effect of growth factors and proinflammatory cytokines that are raised in pre-eclampsia on the secretion of dimeric inhibin A, activin A and follistatin by villous cytotrophoblasts in culture. DESIGN AND METHODS: Villous cytotrophoblasts were prepared from term placentae and cultured in serum-free media. Cells were treated with increasing concentrations of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, transforming growth factor (TGF)-beta1, granulocyte and monocyte colony-stimulating factor (GMCSF), inhibin A, activin A and follistatin for 2 days. Culture supernatants were assayed for human chorionic gonadotrophin (hCG), inhibin A, activin A and follistatin as appropriate. Experiments were repeated at least three times with each cytokine or growth factor and the data pooled.
RESULTS: Cytotrophoblasts syncytialise and spontaneously secrete hCG, inhibin A and activin A in culture. Follistatin levels were <20 pg/ml in most experiments. Activin A secretion was increased in culture in a dose-dependent manner by IL-1beta (approximately 150%, P<0.05), TNF-alpha (approximately 35%, P=0.02) and GMCSF (approximately 100%, P<0.01). hCG secretion was inhibited in a dose-dependent manner by TNF-alpha (50%, P<0.05). Inhibin A was stimulated by IL-1beta ( approximately 30%, P=0.05). Inhibin A, activin A, follistatin or TGF-beta1 did not have a significant effect on any measured parameters.
CONCLUSIONS: These data show that inflammatory cytokines increase the secretion of activin A by trophoblasts in culture. The presence of very low levels, or no follistatin (<20 pg/ml) in the culture media suggests 'free' activin A could have autocrine/paracrine effects on cytotrophoblasts. Inhibin A secretion was stimulated by IL-1beta. However, absence of an effect by the other cytokines investigated on inhibin A in this study suggests that the mechanism(s) involved in increasing maternal circulating levels of inhibin A and activin A in pre-eclampsia are controlled differentially.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581011     DOI: 10.1530/eje.0.1450505

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

1.  Reversible increase of serum activin A levels in women with Graves' disease.

Authors:  M Centanni; N Viceconti; S Luisi; F M Reis; L Gargano; F Maiani; A Franchi; G Canettieri; F Petraglia
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

2.  Activin a plays a critical role in proliferation and differentiation of human adipose progenitors.

Authors:  Laure-Emmanuelle Zaragosi; Brigitte Wdziekonski; Phi Villageois; Mayoura Keophiphath; Marie Maumus; Tamara Tchkonia; Virginie Bourlier; Tala Mohsen-Kanson; Annie Ladoux; Christian Elabd; Marcel Scheideler; Zlatko Trajanoski; Yasuhiro Takashima; Ez-Zoubir Amri; Daniele Lacasa; Coralie Sengenes; Gérard Ailhaud; Karine Clément; Anne Bouloumie; James L Kirkland; Christian Dani
Journal:  Diabetes       Date:  2010-06-08       Impact factor: 9.461

3.  Correlation of concentrations of activin A with occurrence and severity of knee osteoarthritis.

Authors:  Lixue Zou; Jun Liu; Hougen Lu
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-09-01       Impact factor: 2.041

4.  Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.

Authors:  Aparna Reddy; Sangeeta Suri; Ian L Sargent; Christopher W G Redman; Shanthi Muttukrishna
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.